Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shin Calcichew D3 is an over-the-counter (OTC) combination drug containing calcium carbonate, magnesium carbonate, and cholecalciferol (vitamin D3). Developed by Alinamin Pharmaceutical (formerly Takeda Consumer Healthcare), it is formulated as a soft chewable tablet with a yogurt flavor (or matcha flavor for the Green T variant) that can be taken without water. It is indicated for calcium supplementation during periods of increased demand, such as pregnancy, lactation, old age, and growth phases in children. Calcium carbonate provides elemental calcium, magnesium carbonate provides magnesium to support calcium absorption and bone health, and cholecalciferol (vitamin D3) enhances the intestinal absorption of calcium.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + cholecalciferol + magnesium carbonate.